Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 5: Vascular Diseases & Diabetic Retinopathy I

14:30 - 16:00 | 05 September | Room: Amphitheatre Havane

Back to Previous

14:30Assessment of hyperreflective foci following bevacizumab or dexamethasone according to duration of macular edema in branch retinal vein occlusion
J. Do Korea, Republic of
14:36A phase 3b, randomized study to compare three dosing regimens of intravitreal aflibercept for diabetic macular edema beyond the first year of treatment: primary outcomes of the violet study
J. Garweg Switzerland
14:42Aflibercept in macular oedema secondary to retinal vein occlusion refractory to previous bevacizumab or ranibizumab: 24 week outcomes
K. Spooner Australia
14:48Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macula oedema who have had a cataract operation?
P. Scanlon United Kingdom
14:54Anatomical and durability outcomes from the BOULEVARD phase 2 trial of faricimab for DME
A. Seres Hungary
15:00Anti-VEGF in retinal vein occlusions: real data for long term outcomes
P. Corazza Italy
15:06Area-under-the-curve analysis of visual acuity following treatment with the 0.19 mg fluocinolone acetonide implant: Results from the Retro-IDEAL study
A. Augustin Germany
15:12Artificial intelligence algorithm that predicts diabetic retinopathy (DR) response to anti-VEGF treatment in patients via deep learning (DL)
Z. Haskova United States
15:18Artificial intelligence screening system for diabetic retinopathy: results from a pivotal multi-center prospective clinical trial
S. Sadda United States
15:24Baseline predictors for visual outcome in diabetic macular edema with good baseline visual acuity – obtain study
C. Busch Germany
15:30Clinical and OCT angiography features of post dengue fever retinal vasculopathy
S. Kabra India
15:36Clinical outcome of diabetic macular edema patients who lost to follow-up for more than 1 year after Anti-VEGF injections
J. Kim Korea, Republic of
15:42Comparing real-world outcomes of intravitreal anti-VEGF therapy for macular oedema secondary to central retinal vein occlusion between a Swiss and UK teaching hospital
S. Ah-Moye United Kingdom
15:48Real-world outcomes with dexamethasone intravitreal implant in the management of retinal vein occlusion in the UK
I. Pearce United Kingdom
Back to Previous

Sign up to EURETINA


© EURETINA All rights reserved